Richard S. Camplejohn
- Cancer Research top 5%
- Cancer Genomics and Diagnostics 9
- Oncology top 2%
- Cancer-related Molecular Pathways 9
- Cancer Cells and Metastasis 7
-
- Lymphoma Diagnosis and Treatment 8
- Rheumatology top 5%
-
- DNA Repair Mechanisms 6
- Cell death mechanisms and regulation 4
- Molecular Biology Techniques and Applications 4
-
- Monoclonal and Polyclonal Antibodies Research 5
- Co-authors
- Cheryl GillettDavid P. LaneD M BarnesR. DoverAmanda L. WoodsPeter A. HallC. C.‐W. YuJohnathan Watkins
- Journals
- British Journal of Cancer (10 papers)The Journal of Pathology (5 papers)Journal of Clinical Pathology (5 papers)
- Partner nations
- United KingdomUnited StatesSpain
In The Last Decade
Richard S. Camplejohn
62 papers receiving 3.0k citations
Hit Papers
Peers
Comparison fields: 5 of 121
- Cancer Research 582
- Oncology 1.1k
- Pathology and Forensic Medicine 514
- Rheumatology 343
- Pulmonary and Respiratory Medicine 736
Countries citing papers authored by Richard S. Camplejohn
This map shows the geographic impact of Richard S. Camplejohn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard S. Camplejohn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard S. Camplejohn more than expected).
Fields of papers citing papers by Richard S. Camplejohn
This network shows the impact of papers produced by Richard S. Camplejohn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard S. Camplejohn. The network helps show where Richard S. Camplejohn may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Richard S. Camplejohn, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 15 | |
| 2 | 2006 | 19 | |
| 3 | 2004 | 1 | |
| 4 | 2004 | 48 | |
| 5 | 2003 | 3 | |
| 6 | 2003 | 31 | |
| 7 | 2002 | 16 | |
| 8 | 2002 | 11 | |
| 9 | 1999 | 30 | |
| 10 | 1997 | 165 | |
| 11 | 1996 | 34 | |
| 12 | 1996 | 361 | |
| 13 | 1993 | 20 | |
| 14 | 1992 | 24 | |
| 15 | 1992 | 60 | |
| 16 | 1990 | 31 | |
| 17 | Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: An index of cell proliferation with evidence of deregulated expression in some, neoplasmsbreakdown → | 1990 | 1299 |
| 18 | 1989 | 12 | |
| 19 | 1989 | 19 | |
| 20 | Psoriasis, cell proliferation | 1983 | 27 |
About Richard S. Camplejohn
Richard S. Camplejohn is a scholar working on Cancer Research, Oncology, Pathology and Forensic Medicine, Pharmaceutical Science and Modeling and Simulation, having authored 62 papers that have together received 3.1k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (9 papers), Cancer-related Molecular Pathways (9 papers), Lymphoma Diagnosis and Treatment (8 papers), Cancer Cells and Metastasis (7 papers), DNA Repair Mechanisms (6 papers), Monoclonal and Polyclonal Antibodies Research (5 papers), Cell death mechanisms and regulation (4 papers) and Molecular Biology Techniques and Applications (4 papers). The work is most often cited by research in Cancer Research (582 citations), Oncology (1.1k citations), Pathology and Forensic Medicine (514 citations), Rheumatology (343 citations) and Pulmonary and Respiratory Medicine (736 citations). Richard S. Camplejohn has collaborated with scholars based in United Kingdom, United States and Spain. Frequent co-authors include Cheryl Gillett, David P. Lane, D M Barnes, R. Dover, Amanda L. Woods, Peter A. Hall, C. C.‐W. Yu, Johnathan Watkins, Naushin Waseem and David A. Levison. Their work appears in journals such as British Journal of Cancer, The Journal of Pathology, Journal of Clinical Pathology, Cell Proliferation and International Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.